Policy / Regulatory

China’s NHC Approves 2023 Large Medical Equipment Configuration Licenses, Targets Cancer Treatment

CompanyDrug

Hainan Poly Pharm Wins FDA Nod for Generic Version of UCB’s Vimpat

CompanyPolicy / Regulatory

US Lawmakers Call for Sanctions Against WuXi AppTec and WuXi Biologics Over National Security Concerns

Company

Novartis Begins Review of 70% Stake in Indian Unit, Strategic Options Under Consideration

CompanyMedical Device

Boao Yiling Life Care Center Launches Innovative Dental Technologies Under Pilot Medical Policy

CompanyDeals

Brii Biosciences Acquires VBI Vaccines’ Intellectual Property and Manufacturing Rights in Strategic Deal

Company

LianBio to Wind Down Operations Amid Market Challenges, Announces Special Dividend

Policy / Regulatory

NMPA Launches Pilot Program to Streamline Supplementary Drug Approval Process

Company

Organon Reports Q4 2023 Revenue Growth Driven by Women’s Health and Biosimilars

CompanyDrug

Roche’s Xolair Gains FDA Approval to Combat IgE-Mediated Food Allergies in Patients Aged 1 and Up

CompanyDrug

Ipsen Secures FDA Approval for Onivyde Regimen as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

CompanyDrug

FDA Approves Takeda’s Eohilia as First Oral Therapy for Eosinophilic Esophagitis in Patients Aged 11 and Up